Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A sign announcing the beginning of immunizations against COVID-19 at the Pittsburgh VA Medical Center on in Pittsburgh, Pennsylvania. Photo: Jeff Swensen/Getty Images

Officials in several states have said the federal government told them to expect fewer doses of Pfizer's COVID-19 vaccine next week than originally anticipated.

The big picture: Some 2.9 million doses of the Pfizer-BioNTech vaccine were shipped this week as the U.S. started it's largest vaccination campaign in the nation's history. Health and Human Services Secretary Alex Azar said Wednesday that 2 million more doses of the Pfizer vaccine and 5.9 million doses of the Moderna vaccine could be allocated next week, per CNBC.

  • A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna's coronavirus vaccine for emergency use. The vaccine could get emergency authorization as soon as Friday, per the New York Times.

What they're saying:

  • Washington Gov. Jay Inslee (D) tweeted Thursday that the Centers for Disease Control and Prevention "has informed us that WA’s vaccine allocation will be cut by 40 percent next week — and that all states are seeing similar cuts."
    • "This is disruptive and frustrating. We need accurate, predictable numbers to plan and ensure on-the-ground success. No explanation was given," Inslee added.
  • Illinois Gov. J.B. Pritzker (D) said Wednesday that per "the direction of Operation Warp Speed’s General Perna, that estimate was tightened significantly down to 4.3 million doses shipped nationally next week. The following week, originally projected for another 8.8 million, is also now also scheduled to be 4.3 million," NBC 5Chicago reported.
    • “I now no longer believe projections that are put in front of us by the federal government,” Pritzker added. “Having said that, we’re hopeful that they’re accurate."
  • A spokesperson for Michigan's Department of Health and Human Services told Axios that the state is expected to received fewer doses next week than it originally anticipated. "We were not provided an explanation," Lynn Sutfin said in an emailed statement.
  • A spokesperson for Iowa's Department of Public Health said in a statement on Wednesday that the federal government told state officials that Iowa "as well as all other states, will not receive the volume of vaccine initially anticipated."
    • "It appears our allocation may be reduced by as much as 30%, however we are working to gain confirmation and additional details from our federal partners. It will take us some time to work through next steps and adjust our planning," Sarah Ekstrand added.
  • Officials in Maryland also said they were expecting a reduction in the number of doses they were projected to receive, per the Baltimore Sun.
    • Maryland Gov. Larry Hogan (R) said in a news conference Thursday that his team was still trying to figure out the details of what would be allocated to the state. The federal government "did tell us that while these were projections, every Friday they would give us a confirmation" on what would be shipped the following week.
    • Hogan added that the reductions were not "apparently going to impact our first batches for a week or two."

An HHS spokesperson said in an emailed statement that "reports that jurisdictions’ allocations are being reduced are incorrect. As was done with the initial shipments of Pfizer vaccine, jurisdictions will receive vaccine at different sites over several days."

  • "Operation Warp Speed allocation numbers locked in with states have not been changed or adjusted. Only three official allocations have been provided to states: Week 1 Pfizer allocations were provided Friday, Nov. 20; week 1 Moderna allocations were provided Friday, Nov. 27; and week 2 Pfizer allocations were provided Tuesday, Dec. 15. Those are the only official allocation numbers that have been provided," the spokesperson added.
  • "Operation Warp Speed remains on track to allocate enough vaccine for about 20 million Americans to receive their first doses before the end of the month, pending Moderna receiving an EUA.”
  • McClatchy reported later on Thursday that Tiberius, a Pentagon system used by states to keep track of the vaccines, "had outdated, inaccurate projections for deliveries."
    • “Tiberius has been online for a couple of months, and it’s where a lot of the exercise and planning modules were where they could see potential allocations,” a federal official told McClatchy. “The problem is that they kept those exercising and planning modules in there, and that’s what people were looking at as late as last week.”
    • The Pentagon referred Axios to HHS for comment.

Pfizer said in a statement Wednesday that it has millions of doses "sitting in our warehouse but, as of now, we have not received any shipment instructions for additional doses."

  • "We have continuously shared with Operation Warp Speed (OWS) and the U.S. Department of Health and Human Services through weekly meetings every aspect of our production and distribution capabilities. They have visited our facilities, walked the production lines and been updated on our production planning as information has become available," Pfizer added.
  • Pfizer's statement came after Azar told CNBC on Wednesday that the company has to keep the Trump administration at "arms length" on the manufacturing of its vaccine.

Go deeper: Extra doses of Pfizer vaccine could expand U.S. supply

Editor's note: This story has been updated with the statement from HHS and McClatchy's reporting on Tiberius.

Go deeper

Jan 29, 2021 - World

EU grants conditional approval of AstraZeneca vaccine

Photo: Sunil Ghosh/Hindustan Times via Getty Images

The European Commission on Friday granted conditional approval of the Oxford-AstraZeneca coronavirus vaccine for people 18 years and older.

Why it matters: This is the third vaccine to receive approval from the commission, coming hours after the Emergency Medicines Agency recommended its authorization.

Jan 29, 2021 - Health

WHO says most pregnant women can now receive coronavirus vaccine

A doctor administering Moderna's coronavirus vaccine at a university hospital in Essen, Germany, on Jan. 18. Photo: Lukas Schulze/Getty Images

The World Health Organization has altered its guidance for pregnant women who wish to receive the coronavirus vaccine, saying now that those at high risk of exposure to the COVID-19 or who have comorbidities that increase their risk of severe disease, may be vaccinated.

Why it matters: The WHO drew backlash for its previous guidance that did not recommend pregnant women be inoculated with vaccines made by Pfizer-BioNTech or Moderna, even though data indicated that pregnancy increased the risk of developing severe illness from the virus.

Updated 12 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Coronavirus cases hit a seven-month low — Majority back vaccine proof requirements for travel, schools and work — The race to avoid a possible "monster" COVID variant.
  2. Politics: Oklahoma secures $2.6 million refund for hydroxychloroquine purchase — Why Biden's latest vaccine goal is his hardest yet.
  3. Vaccines: Pfizer begins application for full FDA approval of COVID-19 vaccine — Moderna says its COVID booster shot shows promise against variants.
  4. Economy: U.S. adds just 266,000 jobs in April, far below expectations — Americans' return to the skies could benefit smaller airlines.
  5. World: WHO authorizes China's Sinopharm COVID-19 vaccine for emergency use — Mixed response in Europe to Biden's vaccine patents bombshell.
  6. Variant tracker: Where different strains are spreading.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!